Author:
Meyer Maximilian,Westenberg Jean N.,Jang Kerry L.,Choi Fiona,Schreiter Stefanie,Mathew Nickie,King Conor,Lang Undine E.,Vogel Marc,Krausz R. Michael
Abstract
AbstractUnderstanding drug market dynamics and their underlying driving factors is paramount to developing effective responses to the overdose crisis in North America. This paper summarises the distinct drug market trends observed locally and internationally over the past decade to extrapolate future drug market trajectories. The emergence of fentanyl on North American street markets from 2014 onwards led to a shift of street drug use patterns. Previously perceived as contaminants, novel synthetic opioids became the drugs of choice and a trend towards higher potency was observed across various substance classes. The diversification of distribution strategies as well as the regionalisation and industrialisation of production followed basic economic principles that were heavily influenced by prosecution and policy makers. Particularly, the trend towards higher potency is likely most indicative of what to expect from future illicit drug market developments. Nitazenes and fentanyl-analogues, several times more potent than fentanyl itself, are increasingly detected in toxicological testing and have the potential of becoming the drugs of choice in the future. The dynamic of drug import and local production is less clear and influenced by a multitude of factors like precursor availability, know-how, infrastructure, and the success of local drug enforcement strategies. Drug market dynamics and the current trajectory towards ultrapotent opioids need to be recognised by legislation, enforcement, and the health care system to prepare effective responses. Without significant improvements in treatment access, the implementation of preventative approaches and early warning systems, the mortality rate will continue to increase. Furthermore, there is no mechanism in place preventing the currently North American focused overdose crisis to spread to other parts of the globe, particularly Europe. A system of oversight, research, and treatment is needed to address mortality rates of historic proportions and prevent further harm.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Policy,Pshychiatric Mental Health
Reference66 articles.
1. Dyer O. A record 100 000 people in the US died from overdoses in 12 months of the pandemic, says CDC. BMJ. 2021;375:n2865.
2. Ahmad F, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics [Internet]. 2021 [cited 2023 Jan 24]. Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
3. Krausz RM, Westenberg JN, Mathew N, Budd G, Wong JSH, Tsang VWL, et al. Shifting north american drug markets and challenges for the system of care. Int J Ment Health Syst. 2021;15(1):1–8.
4. Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G. Fentanyl depression of respiration: comparison with heroin and morphine. Br J Pharmacol. 2020;177(2):254.
5. Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission. Lancet. 2022;399(10324):555–604.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献